Decheng Capital Global Life Sciences Fund IV, L.P.
10% owner at CG Oncology; 10% owner at Aardvark Therapeutics.
- Rank
- 699th of 809
- Companies held
- 1
- Largest holding
- CGON, 100.0% of total
- Latest SEC filing
- Feb 14, 2025
- Listed but not counted
- $3.9M
What the $76.2M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| CG Oncology CGON Common Stock | Directly | 930,612 | $81.90 | $76.2M | 100.0% | Form 3, Jan 24, 2024 |
Share counts are the amounts Decheng Capital Global Life Sciences Fund IV, L.P. reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Reported but not counted
These shares appear on Decheng Capital Global Life Sciences Fund IV, L.P.'s filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.
| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Aardvark Therapeutics AARD Common Stock | Through Decheng Capital Global Life Sciences Fund IV, L.P. Held by a company or fund the insider manages | 2,958,887 | $1.00 | $3.0M | — | Form 4, Feb 14, 2025 |
| Aardvark Therapeutics AARD Common Stock | Through Decheng Capital Global Healthcare Fund (Master), LP Held by a company or fund the insider manages | 958,412 | $1.00 | $958K | — | Form 4, Feb 14, 2025 |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 696 | L-5 Healthcare Partners, LLC 10% owner, Alphatec Holdings | $76.5M |
| 697 | Insight Venture Partners (Delaware) X, L.P. Director, nCino | $76.4M |
| 698 | Ziff Davis, Inc. 10% owner, Consensus Cloud Solutions | $76.3M |
| 699 | Decheng Capital Global Life Sciences Fund IV, L.P. 10% owner, CG Oncology | $76.2M |
| 700 | Fifth Era Management Sponsor I LLC 10% owner, Fifth Era Acquisition Corp I | $75.6M |
| 701 | Hcn LP Director, NextDecade | $75.0M |
| 702 | James R Scott Trust, James R Scott & First Interstate Wealth Management Co-TTEEs 10% owner, First Interstate BancSystem | $74.8M |
Other CG Oncology insiders
All CGON insiders- Hong Fang Song$50.3MDirector. #2534 overall
- Arthur Kuan$18.7MChief Executive Officer. #5465 overall
Questions
How much stock does Decheng Capital Global Life Sciences Fund IV, L.P. own?
Decheng Capital Global Life Sciences Fund IV, L.P. holds $76,217,123 in listed stock based on SEC filings and current prices, mostly CG Oncology (CGON). That ranks 699th on the Stock Rich List.
Is this Decheng Capital Global Life Sciences Fund IV, L.P.'s net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
Files jointly with Xiangmin Cui.